Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
memo - Magazine of European Medical Oncology
Erschienen in:

01.09.2016 | editorial

ASH 2015—insights and outlooks

verfasst von: Niklas Zojer

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Excerpt

In this issue you will find reviewed selected presentations from the ASH meeting 2015—hand-picked by expert hematologists. Every year, groundbreaking information is emerging from this meeting. Thus, this issue of MEMO not only offers a privileged glimpse on the meeting itself, but also provides insight into the forefront of hematologic treatment strategies. …
Vorheriger Artikel A welcome statement from the associate Editor-in-Chief
Nächster Artikel Rationale of an economically driven PD1 biomarker development in lung cancer—an academic dilemma
Literatur
1.
Heintel D. Novel strategies in themanagement of chronic lymphocytic leukemia (CLL). ASH meeting 2015. Memo. 2016. doi:10.1007/s12254-016-0285-1.
2.
Nösslinger T. Indolent lymphoma at ASH 2015: new treatment approaches. Memo. 2016. doi:10.1007/s12254-016-0274-4.
3.
Fridrik MA. Practice changing information in aggressive lymphoma, ASH 2015. Memo. 2016. doi:10.1007/s12254-016-0271-7.
4.
Zojer N. Focus on multiple myeloma at ASH 2015. Memo. 2016. doi:10.1007/s12254-016-0283-3.
5.
6.
Clausen J. ASH 2015 – stem cell transplantation. Memo. 2016. doi:10.1007/s12254-016-0276-2.
7.
Feistritzer C, Schmidt S. Reversal of direct oral anticoagulants in hemophilia treatment. ASH meeting 2015. Memo. 2016. doi:10.1007/s12254-016-0284-2.
Metadaten
Titel
ASH 2015—insights and outlooks
verfasst von
Niklas Zojer
Publikationsdatum
01.09.2016
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 3/2016
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-016-0280-6

Weitere Artikel der Ausgabe 3/2016

Rationale of an economically driven PD1 biomarker development in lung cancer—an academic dilemma

  • editorial

A welcome statement from the associate Editor-in-Chief

  • editorial

Indolent lymphoma at ASH 2015: new treatment approaches

  • short review

Novel strategies in the management of chronic lymphocytic leukemia (CLL)

  • special report

ASH 2015 – stem cell transplantation

  • short review

Practice changing information in aggressive lymphoma, ASH 2015

  • short review